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We were interested in investigating the effects of dance movement therapy (DMT) in
a psychiatric outpatient clinic with patients diagnosed with depression. DMT aims to
engage the patients in physical and verbal exploration of their experiences generated
in movement based interaction. The assumption was that DMT, which includes both
physical engagement as well as emotional and social exploration, would alleviate the
mood and psychiatric symptoms. All adult patients (n = 33) included in the study
received treatment as usual (TAU). Twenty-one patients participated in a 12-session DMT
group intervention, and the remaining 12 patients chose to take TAU only. The majority
of the patients suffered from moderate or severe depression, recurrent and/or chronic
type. The effects of the interventions were investigated after the intervention, and at
3-month follow-up. Compared to the TAU, adding DMT seemed to improve the effect
of the treatment. The effect of the DMT was observable whether the patient was taking
antidepressant medication or not. At follow-up, between group effect sizes (ES) were
medium in favor for the DMT group (d = 0.60–0.79). In the DMT group, the within ES
at the 3 months follow-up varied from 0.62 to 0.82 as compared to TAU 0.15–0.37. The
results indicated that DMT is beneficial in the treatment of depressed patients.
Keywords: dancemovement therapy, depression, antidepressants, treatment outcome, group therapy, psychiatric
outpatient clinic
Introduction
The global burden of disease studies show unipolar depression as the leading cause of years lived
with disability (YLD) in adult population throughout the world (WHO, 20131). In Finland in 2013,
mental health problems were the reason for 40% of work disability retirement, and in this group,
depression was the most common problem. Further, mental health problems have been the main
reason for the early retirement since the year 20002.
In Finland, the Current Care Guidelines3 base the treatment of depression on comprehensive
diagnostic, clinical, and psychosocial evaluation. The treatment consists of medication and
1http://www.who.int/healthinfo/statistics/GlobalDALYmethods.pdf
2http://www.findikaattori.fi/fi/76
3Käypähoitosuositus, http://www.kaypahoito.fi/web/english/guidelineabstracts/guideline?id=ccs00062&suositusid=
hoi50023
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psychotherapy (see Kupfer et al., 2012; Holma, 2013). The
recommended brief psychotherapy forms are cognitive,
interpersonal, psychodynamic, and problem-solving focused
psychotherapy. In practice, medication is often the main
intervention to treat depression. It is acknowledged that physical
exercise can be beneficial in the treatment of depression, but it
cannot replace medication and therapy. Treatment programs in
hospital units, day hospitals and outpatient psychiatric clinics
may provide some physical activity, and sometimes also dance
movement therapy (DMT) is used.
The positive effects of physical activity in the prevention of
depression (Brown et al., 2005; Teychenne et al., 2010; Luoto
et al., 2013) and in coping with depression (Harris et al., 2005;
Rimer et al., 2012) are frequently noted. The Cochrane review on
the impact of exercise as a treatment of depression by Rimer et al.
(2012) included 39 studies, totaling 2326 subjects. The review
indicated that exercise was equally effective as antidepressants or
psychological therapies in reducing the symptoms of depression.
Health care providers and sports researchers provide
information on amounts of physical exercise that would be
the minimum needed to gain the health effects for preventing
illnesses, to support the level of functioning in the old age and to
foster good mood and happiness4. However, a physically active
lifestyle is challenged, because the way of living, the methods of
transportation and many occupational and leisurely activities
are becoming increasingly sedentary. In Finland, collectively, the
population is getting less physical activity (Husu et al., 2011) and
thus the connectedness to one’s embodiment is weakening. Lack
of movement and physicality is not only a problem of physical
fitness, but also seems to have repercussions on the experiential
level, i.e., on the level of body image (Pylvänäinen, 2003, 2012;
Koch et al., 2013), which affects social interaction, self-awareness,
cognition, and coping. Interestingly, while physical activity in
the population has decreased, there are statistical records from
the years 1990–2010 documenting a steady increase in the
consumption of antidepressants in the Finnish population
(Finnish Medicines Agency and Social Insurance Institution,
2012). Patients with depression often suffer from ailments,
pain-problems, fatigue, and dissatisfaction with one’s own body.
When depressed, it is a challenge to overcome the experiential
and emotional barriers and reach the benefits of physical exercise
and activity. A treatment intervention such as DMT, which
includes both physical engagement as well as emotional and
social exploration, starting on the level where the patient is,
would be feasible to increase self-awareness and emotional and
social flexibility among depressed patients (Kiepe et al., 2012;
Kolter et al., 2012).
DMT is a form of therapy, which integrates the physical,
emotional, cognitive, and social aspects into treatment (Stanton-
Jones, 1992; Meekums, 2002; Bloom, 2006; Payne, 2006a;
Chaiklin and Wengrower, 2009). DMT aims to engage the
patients in physical and verbal exploration of their experiences
generated in movement based interaction. DMT can be carried
out as individual treatment or in groups. It can be applied
to various populations ranging from children to the elderly,
4e.g., http://www.ukkinstituutti.fi/filebank/64-physical_activity_pie.pdf;
http://www.health.gov/paguidelines/guidelines/default.aspx#toc
and from people with severe psychiatric problems to high-
functioning people, who may be interested in strengthening their
resources and self-development.
One focus in DMT is engaging with movement: becoming
concretely involved in movement activity in the here and
now. The other locus of activity is to be attentive to the
movement experiences and to develop the skills to be conscious
and reflective of them and to communicate about them in
words. The relevant interactional elements in DMT are the
engagement of moving body, the development of body awareness
and mindfulness, and the verbal reflection of the movement
experiences, which focuses on the qualities of the experience
(Meekums, 2002; Capello, 2009; Koch and Fischman, 2011;
Nolan, 2014). It is assumed, that this enables the patient to
connect with the emotional core of his/her experience.
The early meta-analysis of the effects of DMT by Ritter and
Low (1996) included five studies on people with depression.
Two of these studies included psychiatric patients. Revisiting
this meta-analysis, Koch et al. (2007) summarize DMT outcome
research on depression in a conclusion that the effect sizes
in the treatment of depression have ranged from moderate to
strong. A Cochrane review of the effects of DMT on depression
by Meekums et al. (2015) examined the effects of DMT for
depression compared to no treatment or to standard care, to
psychological interventions, drug treatment, or other physical
interventions. Only three studies met the Cochrane review
inclusion criteria, totaling 99 adult subjects and 40 teenage
subjects. When the authors compared group DMT to standard
treatment in adults with depression, DMT reduced symptoms
of depression at follow-up measure, as indicated by clinical
observation using the HAM-D. Due to the poor methodological
quality of the studies and small sample size, the findings of
the effectiveness of DMT could not be considered conclusive.
A recent meta-analysis of the effects of DMT and dance on
health-related psychological outcomes included the evidence
of 23 primary studies (Koch et al., 2014). The meta-analysis
showed moderate effects for quality of life and for depression and
anxiety.
In the treatment of psychiatric patients the impact of DMT has
been positive on body image, the perception of the body and self,
affect, motility and well-being, perception of relationships, and
biography (Koch et al., 2007, 2014). Goodill’s (2005) review of the
DMT outcome research in clinical populations concludes that the
treatment brings favorable changes in the following dependent
variables: vitality, mood, anxiety, mastery, coping-skills, and
body image.
Punkanen et al. (2014) conducted a pilot study where DMT
group was used in the treatment of depressed patients. Twenty-
one depressed adult participants were recruited to participate
in 20 sessions of group DMT, twice weekly. The psychometric
questionnaires were taken before and after the intervention. The
mean score of the primary outcome measure, the BDI, decreased
significantly from the pre- (M = 21.67, SD = 5.26) to post-
measurement (M = 10.50, SD = 5.50), showing that the short-
term, group DMT intervention had a positive effect on patients
with depression.
As depression is so widespread in the population, it is
important to develop its treatment, and if possible, to augment
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the choices of effective treatments. Research on a current
clinical practice in a natural setting is relevant for improving
the treatment of depression. Thus, for the development of
outpatient psychiatric care, we were interested in investigating
the effect of DMT in an outpatient psychiatric clinic. This study
plans to add to the knowledge of the effects of DMT in the
treatment of psychiatric outpatients diagnosed with depression.
The main research question concerned, whether DMT-group
intervention produces alleviation in the symptoms of depression.
We compared DMT + treatment as usual (TAU) with TAU.
Thus, we were interested in whether adding DMT to TAU has
benefits as compared with TAU alone. This information may
provide legitimation for the choices made on the use of DMT in
psychiatric outpatient care.
Methods
Recruitment Procedure
The research plan was approved by the City of Tampere Research
Board, which also is a regional board for ethical research
practices. All participants in the study were recruited from
a psychiatric outpatient clinic, which is a part of specialized
public health care. The patients enter the clinic on a referral
from a physician. The patients’ treatment is carried out by
a multi-professional team, which includes a psychiatrist, a
psychiatric nurse, a psychologist, and a social worker. The clinic
offers pharmacological treatment, individual counseling, and
a selection of group interventions. There are various psycho-
educational groups focusing on coping with psychiatric disorder
and its symptoms. The DMT group (8–12 sessions) has been one
option in the available treatment since 2007. The clinic does not
provide physical exercise groups as a treatment option.
Announcements of the study were posted in the lobbies of
the clinic. The staff received e-mails about the study, inviting
them to tell to patients with depression about the opportunity to
participate. The patient information described the study aiming
at exploring the treatment of depression and its outcome by
comparing TAU and the DMT group intervention.
The inclusion criteria were: depression diagnosis and
depression as primary symptom. The exclusion criteria were
psychosis, suicide attempts or clear suicide plans, diagnosis
of severe personality disorder, diagnosis of current alcohol or
substance abuse problem, or debilitating somatic symptoms.
Patients entered the study voluntarily and could choose between
participating in the DMT group or in the TAU group, where
they received the other treatment options the clinic provides. At
the clinic, the common practice is that the patient can choose,
which of the recommended groups to join. Group participation is
never imposed on the patient. Patients participating in the study
received information about it, their contribution and freedom
to withdraw from the study at any time without consequences
for their access to treatment. All the participants in the study
were recruited between August 2011 and September 2012 and
provided written consent to participate in the study.
Patients joining the TAU group signed the consent, which was
then sent to the researcher. The TAU group participants were
mailed the set of assessment measures at the start of the research
period, after 3 months (12 weeks) and after 6 months since the
first measurement point. The replies could be sent in stamped,
addressed envelope.
Patients interested in joining the DMT group came to a
recruitment interview according to the normal practice. At the
end of the interview the patient could decide whether to agree
to participate in the research and sign the consent form. After
the interview, the set of self-evaluation measures was sent to
the patient via mail and s/he mailed them back in a stamped
addressed envelope. This procedure aimed at distancing the
research aspect of the group and the therapy process. Similarly
to the TAU group, the measurements were completed at the start
of the intervention period (pre), after the 3-months (12-weeks)
DMT intervention (post) and after 3 months (follow-up).
During the data collection period, a total of 25 patients were
recruited for the DMT groups. Sequentially, they formed four
groups. The therapist/researcher worked with one group at a
time. Four patients were excluded from the sample on the basis
of the inclusion criteria. Thus, 21 patients could be included in
the study, and 19 completed all measures. Two patients did not
respond to the self-evaluation measures after the treatment or
at the follow-up measurement, but they were included in the
statistical analysis. In the DMT group, 84% of the participants
stayed in the study and in analyses.
The TAU groups were collected at the same time as the
DMT groups. A total of 18 patients joined and provided written
consent. Twelve patients answered the pre-measurement self-
evaluations and were included in the study. However, only eight
patients completed the self-evaluations at all three measurement
points. In the TAU group, 67% of the initial participants who
completed the first evaluation stayed in the study. Supplementary
Figure A summarizes flow of the data collection.
Selecting the sample and assigning the groups this way
creates a quasi-experimental research design, as there is no
randomization. This limits the validity of the results, but this
design was chosen in order to remain close to the everyday
practices of the clinic. Also, it was assumed that self-selection to
the groups would minimize the drop-out rate in the DMT group.
Participants
The background information presented on the participants is
based on the patient records (see Table 1). About 60% (57.5%)
of the participants had two or more psychiatric diagnoses. On
the basis of the patient records, in the TAU group the most
common diagnoses were F32.1—moderate depressive episode
(42%) and F32.2—depression severe/major without psychotic
symptoms (25%). In the DMT group themost common diagnosis
was F32—major depressive disorder, single episode (29%) and the
total percentage of patients with F32-range diagnoses was 43%. In
the DMT group, 19% of the participants had an F33 diagnosis—
recurrent depressive episode. During the treatment period at
the clinic, the medical examination indicated the severity of
depression to be moderate or severe in the majority of patients
in both groups.
In the whole group, there were five patients, whose primary
diagnosis was of anxiety or eating disorder or in the personality
disorder range. This reflects the common clinical situation in
Frontiers in Psychology | www.frontiersin.org 3 July 2015 | Volume 6 | Article 980
Pylvänäinen et al. DMT treatment effects
TABLE 1 | Participant data at the pre-measurement—depression
characteristics.
Descriptives of subjects DMT TAU Total
at pre-measurement group group
N 21 12 33
Gender Male 5(23.8%) 4(33.3%) 9(27.7%)
Female 16(76.2%) 8(66.7%) 24(72.7%)
AgeM (SD) 42(12.7) 38(10.4) 41(11.9)
Min 20 Min 22 Min 20
Max 59 Max 55 Max 59
Number of diagnosis 1 7(33.3%) 7(58.3%) 14(42.4%)
2 10(47.6%) 4(33.3%) 14(42.4%)
3< 4(19.1%) 1(8.3%) 5(15.1%)
Severity of depression
(psychiatrist’s recorded
assessment)
Mild 5(23.8%) 1(8.3%) 6(18.2%)
Moderate 9(42.9%) 7(58.3%) 16(48.5%)
Severe 5(23.8%) 4(33.3%) 9(27.3%)
Not assessed 2(9.5%) 0(0.0%) 2(6.1%)
Years since first
episode of depression
1 1(4.8%) 4(33.3%) 5(15.2%)
2–3 4(19.1%) 1(8.3%) 5(15.2%)
4–8 11(52.4%) 3(25.0%) 14(42.5%)
9–25 5(23.8%)
M = 7.9
years
4(33.3%)
M = 6.4
years
9(27.1%)
M = 7.4
years
Significant relational
stress in history or
currently
Yes 20(95.2%) 12(100%) 32(97.0%)
No 1(4.8%) 0(0%) 1(3.0%)
specialized psychiatric care, that patients’ depression is rarely just
plain depression. This is also reflected a in the second diagnoses
the patients had. Of the whole group 58% had a second diagnosis.
Twenty-four percent of these second diagnoses related to soma:
pain, heart, lungs, diabetes, hyperkinesis. Fifteen percent of the
second diagnoses related to anxiety. In the whole group, 18% of
the patients reported a history of alcohol abuse.
Themean duration of time since the first episode of depression
was 6.4 years in the TAU group and 7.9 years in the DMT
group. The mean length of the current treatment period was
16 months in the TAU group and 21 months in the DMT
group. At the pre-measurement, for the majority of the patients,
the length of the current treatment period was less than
12 months.
In the TAU group, all the patients were taking antidepressant
medication (Table 2). In the DMT group, 57% of the participants
were taking antidepressant medication, 43% (nine patients) were
not. The difference in the use of medication between the DMT
and TAU groups was statistically significant (x2 = 7.07, df = 1,
p < 0.01). One reason for the referral to the psychiatric unit was a
medication resistant depression, where the patient did not benefit
from antidepressants. In the DMT group, 38% of the patients
were taking some other medication for psychiatric reasons, and
in the control group 42%.
TABLE 2 | Participant data at the pre-measurement—treatment
features.
Descriptives of DMT TAU Total
participants at baseline group group
N 21 12 33
Duration of the current
treatment period
>6 months 10(47.7%) 5(41.7%) 15(45.5%)
7–12 months 6(28.5%) 4(33.3%) 10(30.3%)
13–35 months 3(14.4%) 1(8.3%) 4(12.0%)
36–96 months 2(9.5%)
M = 21.1
2(16.6%)
M = 15.8
4(12.0%)
M = 14.24
Antidepressant
medication
Yes 12(57.1%) 12(100%) 24(72.7%)
No 9(42.9%) 0(0%) 9(27.3%)
Other psychotropic
medication
Yes 8(38.1%) 5(41.7%) 13(39.4%)
No 13(61.9%) 7(58.3%) 20(60.6%)
Frequency of individual
counseling/therapy at
pre-measurement
1x/week 1(4.8%) 0(0.0%) 1(3.0%)
every other week 3(14.3%) 3(25.0%) 6(18.2%)
every 3–4 weeks 7(33.3%) 5(41.7%) 12(36.4%)
5 or more weeks
interval
9(42.9%) 4(33.3%) 13(39.4%)
none 1(4.8%) 0(0.0%) 1(3.0%)
Psychoeducational
group experience
Yes 4(19.0%) 11(91.7%) 15(45.5%)
No 17(81.0%) 1(8.3%) 18(54.5%)
Psychotherapy
experience
Yes 12(57.1%) 3(25.0%) 15(45.5%)
No 9(42.9%) 9(75.0%) 18(54.5%)
In the DMT group, 57% of the patients had experience
of psychotherapy and in the TAU group 25%. At the pre
measurement, in the TAU group 92% of patients had experience
of psychoeducational groups and in the DMT group 19%. The
difference was statistically significant (x2 = 16.24, df = 1,
p < 0.01), and was due to the fact that seven patients (64%) in
the TAU group were participating in a psychoeducational group
for depressed patients during the evaluation of the intervention.
Intervention Procedure
Both the DMT and the TAU group received individual counseling
during the study. In the TAU group 33% of the patients had
an individual counseling appointment every 5 weeks or less
frequently, and 25% had counseling every 1–2 weeks. In the DMT
group 67% of the patients had counseling every 5 weeks or less
frequently, and 20% every 1–2 weeks.
The DMT intervention was delivered by a psychologist and
dance movement therapist trained in the DMT methods of
Marian Chase and in authentic movement. The essence of the
Chacian approach is engaging in improvised, shared movement,
and creating an interactional space through movement (Levy,
1992; Fischman, 2009). The Chacian method is primarily a
DMT form of group therapy. Authentic movement, initially
developed by Mary Whitehouse and Janet Adler, can be applied
as a method in individual or group therapy (Payne, 2006b).
The application of authentic movement based practices in DMT
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in psychiatric outpatient care means emphasizing the non-
judgmental empathetic witnessing of movement expression as
it appears, the cultivation of conscious awareness of movement,
and the allowing of the person to be visible and seen in his/her
movement (Adler, 1999; Penfield, 2006). Both the Chacian
method and authentic movement promote the integration of
intra-actional (within the individual) and interactional (relating
with the environment) systems (Capello, 2009).
The DMT group intervention consisted of 12
dance/movement therapy sessions (one session a week for
12 weeks). Each session was 90min long and included discussion
(20–40min), movement warm-up and process (30–40min) and
a verbal reflection and closure of the movement experience (15–
30min) facilitated by a dance/movement therapist-psychologist.
The therapy groups were small with 4–7 participants. The
guiding principles for the group facilitation were:
• supporting the safety in the body by paying attention to
grounding in the movement, body boundaries, respect for
personal space, and the mover’s position as a modulator of
his/her own movement
• supporting the sense of agency by emphasizing the choice
making in movement, paying attention to the ways one uses
one’s body in movement and interaction, recognizing the
resources the body offers
• supporting mindfulness skills by paying attention to the
experience of the body sensations, movements, and states,
fostering the ability to verbalize these as well as the emotions
and imagery relating to the body sensations
• being attentive to interaction by paying attention to body
responses in the group interaction situations, acknowledging
the impact of expectations, and anticipation in the body
responses
• fostering the interaction by being present and attentive to
the patients, conveying seeing and hearing them as they are,
respecting the body experience, and encountering via shared
movement qualities
As DMT is based on interaction, the group facilitation in practice
was an integration of these principles, pre-planned structures and
themes, and responses to the needs and themes of the group
in the moment. The same therapist working with each group
was the constant factor. All sessions included a discussion at the
start and after the movement explorations. The discussions were
oriented toward expressing embodied experiences and reflecting
on them. Discussions also echoed the process and needs of the
group. Table 3 presents a model of the 12-sessions group process.
Outcome Measures
The background information assessment included the patient’s
gender, date of birth, diagnosis, duration of illness, severity of
depression, use of medication, and the treatment received by
the time of answering the inquiry. The researcher/therapist had
also had access to the research subjects’ patient records. The self-
evaluation measures used in the study and reported in this paper
were: BDI-II, HADS, SCL-90, and CORE-OM.
BDI-II (Beck Depression Inventory) and HADS (Hospital
Anxiety and Depression Scale) measure mood. BDI-II (Beck
et al., 1961, 1996; Dozois et al., 1998) measures depressive
symptoms. The score range is 0–63. Higher points indicate more
severe depression (0–13 indicates no or very few depressive
symptoms, 14–19 indicates mild depression, 20–28 moderate
depression and 29–63 severe depression). HADS screens for
depression and anxiety symptoms (Norton et al., 2013).
HADS is indicating symptoms, when the score is above 8 in
anxiety (HADS-A) and depression scales (HADS-D), respectively
(Bjelland et al., 2002), or when the total score is ≥9 (Kjærgaard
et al., 2014). Both BDI-II and HADS are frequently used in
clinical assessment of depression.
The SCL-90 (Symptoms Check List- 90) is a psychiatric
self-report inventory consisting of 90 questions. The questions
assess a wide range psychiatric symptoms, including depression,
anxiety, and somatization (Holi, 2003). Many of the symptoms
reflect bodily states and autonomous nervous system arousal. A
single number representing the severity of the patient’s condition
is GSI (global severity index), which is the average score of the 90
questions of the inventory.
CORE-OM (Clinical Outcomes in Routine Evaluation—
Outcome Measure) shows the patient’s experience of his/her
mood and interactions with others and environment. It addresses
the patient’s global distress and portrays the dimensions of well-
being, problems, life functioning, and risk for aggressive/suicidal
behavior. Between the general and clinical populations, the
clinical cut-off point is 10 points (Connell et al., 2007) or as a total
mean score for women 1.29 and for men 1.19 (Evans et al., 2002).
CORE-OM is sensitive to change in condition. The CORE-OM
all-items score has a correlation of 0.81 with BDI-II and 0.88 with
SCL-90-revised version. CORE-OM is applicable to a wide range
of populations. It can be used for assessing clinical effectiveness
of various models of therapy (Evans et al., 2002).
The self-evaluation measurements were presented to the
participants at the start (pre-assessment), after 3 months (post
assessment), and 3 months after the end of the intervention
(follow-up assessment).
Statistical Analysis
Baseline between-group differences in demographic data and
pre-treatment measures were analyzed with independent t-tests
and chi-square tests, or using Mplus statistics (see below). The
effects of interventions were analyzed using hierarchical linear
modeling (HLM) in Mplus (version 7) (Muthén and Muthén,
2012). The most important advantage in using HLM with full
information maximum likelihood (FIML) estimation method
instead using repeated measures ANOVA/MANOVA is that it
uses all the available information. Thus all participants who
started the study (DMT, n = 21, TAU, n = 12) were included
in the analyses. The missing data in HLM&FIML is supposed
to be Missing At Random (MAR). ANOVA/MANOVA approach
uses listwise deletion requiring that the missing data have to be
Missing Completely At Random (MCAR). This listwise deletion
has a greater effect on statistical power than the HLM/FIML
method. The HLM uses a full information approach, with
standard errors that are robust in the case of a non-normal
distribution (MLR estimator in Mplus). The analyses were as
follows. First, the group x time interaction was tested with Wald
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TABLE 3 | A group model based on the integration of the four different DMT group processes.
Theme Process exercises
1 Introduction, start Circular motion in joints.
Improvisation with name gestures.
With picture cards, expressing one’s expectations of the DMT group.
2 Familiarizing with the space, moving, and collaboration Exploring the space/room by moving in it in various ways and acknowledging the others.
In a dyad, reflecting each other’s movement.
3 Safety and agency, playfulness Recognizing how one directs attention: outwards, inwards.
Sensing body boundaries.
Moving eyes open or closed.
Exploring the spatial options in movement.
4 Playfulness, agency, finding different options Exploring spine motility.
Imagery and improvisation: If you were an animal, how would the animal move?
In a circle, moving by holding hands.
5 Intuition, sensitivity Activation of the body, starting from the feet.
Playing with different movement qualities.
Mindfulness skills and breathing: sensing one’s walking.
6 Relieving achievement pressure Sensing hands through different movements.
Breathing exercises.
Bartenieff Fundamentals* basic exercises.
Mindfulness skills: breathing and seeing the other.
Polarity: familiar and unfamiliar in movement.
7 Boundaries, distances, directions Activating hands and breathing, sensing body boundaries, sensing center/core also with
strength.
Movement improvisation with a focus on near space, middle space, far space.
Walking in a dyad and sensing the connection.
Drawing a picture of one’s experience.
8 Space for motion, boundaries, surfaces—balancing being, and action Self-nurturing movement and moving on the floor level.
Bartenief Fundamentals* basic exercises.
Getting into vertical slowly and through different postures.
9 Emotion—acceptance and agency in one’s life and in relation with
environment/others
Movement improvisation from the words selected to express one’s present state.
Exploring earth, water, air, and fire through movement improvisation—expressing and
describing associated feelings.
10 What do I need—attention and focusing in action In a dyad, hand massage.
On a tape line, improvising movement in relation to the line; working with a partner who
accompanies the movement in the way one asks for.
11 Accepting needs—nurturing, simplicity, freedom Moving with breath, gradually engaging the whole body.
Simple qigong exercise (breath, clear movement pattern, a sense of opening/stretching,
focusing).
Requesting from a pair something one needs in movement and/or presence.
Homework: to write a poem of one’s experiences in this group.
12 Closure—what have I learnt? Activating the body, grounding, being aware of the body.
Simple qigong exercise (same as in the session 11)
Poems: sharing them, improvising movement on them.
Feedback of the process.
*See Bartenieff and Lewis, 1980.
test. Secondly, if the interaction was statistically significant the
group differences were tested for the intervention period (pre to
post), and follow-up period (post to follow-up) separately.
Effect sizes (ES) were calculated as follows. The between-
groups ES was calculated after the treatment and at follow-
up by dividing the difference between the DMT group mean
and the TAU group mean by the pooled standard deviation
of the two conditions. The within-group ES was calculated for
both the post- and follow-up measurements by dividing the
mean change from pre-measurement by the combined (pooled)
standard deviation (SD) (Feske and Chambless, 1995; Morris and
DeShon, 2002). Due to possible differences between groups at
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pre-measurement, between-group ES differences at post- and at
follow-upmeasurements were corrected by the pre-measurement
difference. Thus, corrected between-group ES were reported.
A between-group effect size of 0.2 was considered small, 0.5
was medium, and 0.8 was large. A within-group ES of 0.5 was
considered small, 0.8 was medium, and 1.1 was large (Roth and
Fonagy, 1996; Öst, 2006).
Results
Symptom Measurements
At the pre-measurement, the groups were statistically
significantly different in their BDI-II -scores (DMT group
m = 25.00, sd = 11.70; TAU group m = 32.50, sd = 7.60;
Estimate = −7.50, p = 0.026) and CORE-scores (DMT group
m = 17.00, sd = 6.61; TAU group m = 20.65, sd = 3.55;
Estimate = −3.66, p = 0.036). BDI and CORE described
the depression symptoms and psychiatric condition to be
more severe in the TAU group than in the DMT group at the
pre-measurement. Based on the HADS and SCL-90 scores,
the groups were not statistically significantly different at the
pre-measurement.
Symptoms (SCL-90) decreased more in the DMT group than
in the TAU group during the study period.When the intervention
and follow-up periods were analyzed separately it was observed
that SCL-90 scores changed statistically significantly differently
in the DMT and TAU groups during the intervention (Estimate
= −0.425, p = 0.011) but not during the follow-up (Estimate
= 0.031, p = 0.086). In the HADS scores, there was a trend for
a significantly different change over the three measures. During
the intervention the scores changed statistically significantly
differently between the DMT and TAU groups (Estimate =
−6.295, p = 0.024), but not during the follow-up (Estimate =
0.741, p = 0.714). In the BDI-II- and CORE-scores there was
a greater reduction in the DMT group than in the TAU group,
but over time, the groups did not change statistically significantly
differently (Table 4).
To assess the size of the treatment effects, effect sizes were
analyzed (see Supplementary Table 1). Between groups ES showed
large differences (d ≥ 0.80) at post measurement in HADS and
CORE, and medium size (d ≥ 0.50) in BDI-II and SCL-90. At
follow-up between groups ES were medium in favor of the DMT
group (d = 0.60–0.79). The difference in HADS at 3-month
follow-up was close to large (d = 0.79). In the DMT group,
the with-in group ESs were medium or close to medium size at
post measurement BDI-II (d = 0.87), HADS (d = 0.92), and
CORE (d = 0.76), and small in SCL-90 (d = 0.57). In the
follow-up the within ES were medium for HADS (d = 0.83)
and close to medium in BDI-II (d = 0.75). ESs were small for
CORE (d = 0.71) and SCL-90 (d = 0.62). In the TAU group
the within ESs were small (BDI-II, d = 0.47) or very small
(HADS, d = 0.23; SCL-90, d = 0.02; CORE, d = 0.18) at post
measurement. The within ESs were also small in the follow-up
(BDI, d = 0.37; HADS, d = 0.31; SCL-90, d = 0.15; CORE,
d = 0.26). Thus, in the DMT group the within ESs at the 3-
month follow-up varied from 0.62 to 0.82 as compared to TAU
0.15–0.37.
TABLE 4 | Mean scores and standard deviation for depression (BDI-II),
anxiety and depression (HADS), physical and psychological symptoms
(SCL-90), and global distress (CORE) at pre, post, and 3-month follow-up.
Out- Pre M Post M Fup 3-mo Wald test P-value
come (SD) (SD) M (SD) df = 2
BDI-II 2.93 0.231
DMT 25.00(11.70) 14.89(13.60) 16.24(13.62)
TAU 32.50(7.60) 28.97(8.65) 29.66(9.85)
d −0.67 −0.60
HADS 5.39 0.068
DMT 20.81(7.99) 13.43(10.24) 14.22(9.85)
TAU 24.58(4.65) 23.54(6.47) 23.15(7.75)
d −0.97 −0.79
SCL-90 8.23 0.013
DMT 1.39(0.76) 0.95(0.74) 0.91(0.67)
TAU 1.59(0.41) 1.58(0.37) 1.53(0.55)
d −0.70 −0.67
CORE 4.14 0.126
DMT 17.00(6.61) 11.95(7.96) 12.31(7.02)
TAU 20.65(3.55) 20.05(4.55) 19.78(6.04)
d −0.85 −0.73
Between-group effect-sizes (d) are also presented (corrected with pre-measurement
difference).
Differences between the Groups on the Basis of
the Use of Antidepressants
When analyzing the data on the subjects’ use of medications,
it was revealed that all the patients in the TAU group
(n = 12) were on antidepressive medication, but in the
DMT group there were nine patients, who were not taking
antidepressants, leaving 12 with antidepressants.Table 5 presents
the differences that can be observed when the subjects are
grouped on the basis of the DMT intervention and the use of
medication.
The duration of the participants’ illness, the length of the
current treatment period, and the measurements score level
differed according to the use of antidepressant medication.
Compared to no-antidepressants patients, patients taking
antidepressive medications had suffered longer from their
illness and had more severe psychiatric symptoms at the
pre-measurement point. The TAU group participants on
antidepressive medication had the most severe psychiatric
symptoms in this material. However, the mean duration of their
illness and the length of the current treatment period were
shorter than in the subgroup of DMT antidepressant users. Since
medication could have affected the results we decided to conduct
additional analyses. We were especially interested to ascertain, if
the DMT group onmedication showed a different change pattern
from that in the TAU group (on medication). Further, we were
also interested in comparing the members of the DMT group
with medication and without medication.
Wald test showed that the DMT group with medication
changed differently from the TAU group (on medication) during
the intervention regarding the scores on SCL-90, Wald test =
13.46, df = 2, p = 0.001. In this comparison, the change was
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TABLE 5 | Differences between outcomes in the DMT and TAU groups when the subgroup distribution is based on DMT intervention and taking
antidepressants.
Variable DMT group, pts taking DMT group, no TAU group, pts taking
antidepressants n = 12 antidepressants n = 9 antidepressants n = 12
Mean duration of the treatment period 17 months 10 months 15 months
Years since first episode of depression (mean) 10 years 5 years 6 years
INVENTORY M SD M SD M SD
BDI-II Pre 25.58 10.43 24.22 13.16 32.50 7.60
Post 18.02 13.76 11.55 11.92 28.97 8.65
Follow-up 19.59 11.88 13.36 14.77 29.66 9.85
HADS Pre 20.67 7.00 21.00 9.13 24.58 4.65
Post 15.67 10.57 11.00 9.06 23.54 6.47
Follow-up 16.96 10.01 11.22 8.57 23.15 7.75
SCL-90 Pre 1.45 0.67 1.30 0.86 1.59 0.41
Post 1.06 0.80 0.81 0.63 1.58 0.37
Follow-up 1.03 0.75 0.77 0.54 1.53 0.55
CORE Pre 17.54 5.53 16.13 7.95 20.65 3.35
Post 13.44 7.79 10.21 7.70 20.05 4.55
Follow-up 13.36 7.07 10.77 6.50 19.78 6.04
statistically significantly different during the intervention period
(Estimate = −0.378, p = 0.008), but not during the follow-up
period.
The HADS scores showed a tendency for a statistically
significantly different change pattern when comparing the DMT
with no medication and the TAU group (Wald test = 5.472,
df = 2, p = 0.06). In this comparison, the change was
statistically significantly different during the intervention period
(the Estimate= −8.936, p = 0.026). During the follow-up period
there was no statistically significant change.
In all other comparisons Wald test did not reveal any
statistically significant difference. As there were no statistically
significant differences between the score changes of the DMT
group with no medication and DMT with medication subgroups,
DMT appears to be effective whether the patient is taking
antidepressive medication or not.
At the post-measurement, assessing the clinical significance
of the changes after the intervention period, the greatest
improvements in the condition appeared in the group of DMT
participants who were not on antidepressant medication (see
Supplementary Table 2). In this group, the within-group pre to
post effect sizes ranged from d = 0.56 to d = 1.07, i.e., from small
to medium. The effect sizes in the pre- follow–up measurements
comparison ranged from small to large, d = 0.62–1.10. The
DMT participants on antidepressants had also clearly improved,
but the within-ES changes were slightly smaller than for the
DMT participants not on antidepressants. In the DMT group
on antidepressants the range of effect sizes (d) was 0.59–0.76 at
the pre-post measurements comparison, and at the pre-follow-
up comparison the range was from d = 0.53 to d = 0.71; thus
in this group the ESs were small. In the TAU group, where all the
patients were on antidepressant medication, the changes in the
scores during the data collection time were minor. The range of
within-group effect sizes (d) was 0.02–0.47.
Discussion
This study investigated the effect of adding dance/movement
group therapy (DMT) to the treatment of psychiatric outpatients
with a diagnosis of depression. Compared to the TAU, adding
DMT seemed to improve the effect of the treatment. There was a
tendency for the effect of DMT to be slightly better with patients
who were not taking antidepressive medication.
Between-group effect sizes between the DMT+TAU and TAU
indicated medium or large differences (d = 0.60–0.85) in the
four measures used in this study in favor of the DMT + TAU. In
addition, the within-group effect sizes were considerably larger
among patients attending to the DMT group. This suggests, that
the favorable changes observed when the DMT was added to the
TAU may have clinical significance. However, more studies are
needed to confirm the clinical effects of DMT.
The indication of a statistically significantly greater
improvement between the DMT + TAU and TAU groups
appeared in the SCL-90 measuring psychiatric symptoms and
HADS measuring depression and anxiety symptoms. In these
self-evaluation assessments, the verbal content of the statements
is geared toward bodily felt sensations, symptoms, and emotions.
In the SCL-90 one third of the questions refer to somatization
or phenomena that relate to autonomous nervous system
arousal. This may be one reason why the change was expressed
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more clearly through these measurements. In addition to these
changes, the DMT group showed favorable changes, although
not statistically significant, in symptoms of depression (BDI-II)
and global distress (CORE-OM). These observations are in
line with the study by Punkanen et al. (2014) using a similar
DMT group intervention. In their study the mean decrease on
the BDI from baseline to post-measurement was 11.17 points
compared to 10.11 points in the present study. Both these
studies produced a similar favorable outcome in the treatment
of depression. Punkanen et al. (2014) used a 20-session group
intervention provided twice a week while the present study
applied a 12-session intervention. This suggests that favorable
changes could also be achieved using a shorter DMT group
intervention.
The observations made in this study are also in accordance
with the previous reviews by Meekums et al. (2015), Koch et al.
(2014), and Papadopoulos and Röhricht (2014). These suggested
positive effects of DMT on quality of life and on depression and
anxiety. One focus in DMT is engaging with movement activity
in the here and now. Further, the aim of activity is to be attentive
to the movement experiences and to develop the skills to be
aware of experiences, and to communicate about them in words
(Meekums, 2002; Koch and Fischman, 2011; Nolan, 2014). Thus
DMT involves experiential exercises including mindfulness skills
and attention training. There are several other studies suggesting
that this type of training, which includes experiential exercises,
could be beneficial to the patients (Hayes et al., 2011; Michalak
et al., 2012; Horst et al., 2013; Payne, 2015). It could also be
speculated that DMT increases psychological flexibility, which
has been shown to be associated with wellbeing and quality of life
(Hayes et al., 2011; Keng et al., 2011), as the skills for observation,
reflection and body state modulation improve. Thus, given that
DMT is a useful interventionmethod for patients with depression
symptoms, more studies are needed to examine the possible
mechanism of change.
A tendency was observed for the greatest improvement the
be achieved when the patient participated in the DMT group
and was not on antidepressive medication. However, it should
be noted that the patients in the DMT group without or with
antidepressant medication benefited from the intervention, and
no statistically significant differences were observed between
the groups. Thus, more studies are needed to investigate the
impact of DMT interventions with or without medication.
The importance of observing medication in the treatment is
emphasized by the fact that the more difficult symptomology
appears to go along with more complex diagnosis set, longer
treatment period, and taking of medication. We observed that
those patients not taking medication had typically had current
treatment periods under 6 months (67% of the patients) and only
one diagnosis (44% of the patients). Those patients, who used
medication at the pre-measurement, had typically two or more
diagnosis (63% of the patients) and had more than 6 months of
treatment (63% of patients).
When comparing DMT + TAU to TAU among patients on
antidepressant medication, it was observed that all the four
outcome measures tended to improve more in the DMT group,
with especially SCL-90 showing significantly larger change. It is
of particular interest that at the pre-measurement point in the
DMT group, the patients on antidepressive medication and those
without antidepressive medication had a fairly similar level of
symptoms, but the score differences between these two subgroups
had clearly increased at the post-measurement, in favor of no
antidepressants sub-group. The question arises as to whether the
DMT participants on antidepressants had a more difficult type of
depression and the medication had alleviated their symptoms so
that their symptom scores were on the level of a less complicated
depression at the pre-measurement point. If this was the case,
it could be assumed that the smaller score changes after the
intervention could have been due to the more difficult type of
depression.
This study has limitations to be born in mind when drawing
conclusions from the results. One concern is the use of self-
evaluation measures only, and the lack of movement based
assessment of the effects of the intervention. Videotaping the
sessions was not part of the usual clinical practice at this
clinic, and the goal was to study the natural clinical practice.
Without video recordings it is difficult to produce any reliable
movement assessment of the four groups. Even with video
recordings, movement observation of group activity would have
been challenging to carry out reliably.
The participants joined the research groups on the basis
of self-selection. They were not randomly divided among the
groups. Thus, we cannot ignore the possibility that the selection
bias has affected the results. In fact, at the pre-measurement
point the TAU group reported significantly higher value for
depression symptoms and global distress compared to the DMT
+ TAU. On the other hand, the DMT group had a slightly
longer history of illness, more frequently two diagnoses and
more frequently an experience of psychotherapy than the TAU
group patients. Also, as more patients in the DMT group had
experience of psychotherapy, it is possible that DMT attracts
patients who are positively disposed to therapeutic work, willing
and able to use self-reflection and interaction as means for
their recovery. Both the DMT and the TAU group participants
may have had expectations about the treatment they received.
As we did not systematically assess their expectations, we can
draw no conclusions of the impact of expectations on the
results.
Further, the follow-up time was relatively short (3 months),
thus in light of the current data it is difficult to draw firm
conclusions about the long-term effects of DMT. Another
limitation is the small number of participants included in the
study. In the TAU group there was a fairly high drop-out
rate. However, we applied hierarchical linear modeling in data
analyses, since it included all the patients who started the
treatment. According to the patient records, all the patients who
left the research did continue their treatment at the psychiatric
clinic over the study period. No data were collected about their
reasons for leaving the study.
The TAU patients were not interested in joining the DMT
group, but this study offers no information about their reasons
for this. Compared to the TAU group, a higher percentage of
the DMT group patients continued in the study. This prompts
a question, whether the participation in the DMT group,
Frontiers in Psychology | www.frontiersin.org 9 July 2015 | Volume 6 | Article 980
Pylvänäinen et al. DMT treatment effects
personal commitment and joining the interaction supported the
motivation for treatment and also the alleviation of depression.
If this was the case, DMT seems to offer a suitable social context
to be utilized in health care to offer new interactional experiences
and learning through them.
The TAU did not significantly improve the patients’ wellbeing.
This study suggests that experiential treatment methods such as
DMT could improve the effects of treatment. However, not all
clients want to join a DMT group as was observed in this study.
In the future, more attention could be devoted for increasing
patients’ motivation for experiential and action based treatment
methods.
The results indicated that adding DMT to TAU is beneficial
in the treatment of patients with depression. These results
encourage the use of creative, interactive, psycho-physical,
and experiential therapy interventions in the treatment of
depression.
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